MAIA Biotechnology

IN THE PRESS

Press Releases

MAIA Biotechnology to Present at BIO International Convention 2025

June 10, 2025

·

6 min read

Press Releases

MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical Trial

June 5, 2025

·

5 min read

Press Releases

MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer

June 5, 2025

·

5 min read

Press Releases

MAIA Biotechnology Announces Private Placement of Approximately $669,500

May 28, 2025

·

4 min read

Press Releases

CORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000

May 27, 2025

·

5 min read

Press Releases

MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

May 15, 2025

·

6 min read

Press Releases

MAIA Biotechnology Announces Director Participation in Recent Private Placement

May 14, 2025

·

5 min read

Press Releases

MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders

April 1, 2025

·

4 min read

Press Releases

MAIA Biotechnology Announces Poster Presentation at ESMO’s European Lung Cancer Congress 2025

March 25, 2025

·

5 min read

Press Releases

MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug

March 20, 2025

·

6 min read

JOBS